{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:35:27Z","timestamp":1783532127149,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,5,5]],"date-time":"2007-05-05T00:00:00Z","timestamp":1178323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s00277-007-0301-y","type":"journal-article","created":{"date-parts":[[2007,6,21]],"date-time":"2007-06-21T16:33:09Z","timestamp":1182443589000},"page":"565-568","source":"Crossref","is-referenced-by-count":39,"title":["Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas"],"prefix":"10.1007","volume":"86","author":[{"given":"Luigi","family":"Rigacci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Nassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Puccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ennio","family":"Polito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Dal Pozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Alterini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Carrai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Puccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,5,5]]},"reference":[{"key":"301_CR1","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1182\/blood-2006-02-005017","volume":"108","author":"D Decaudin","year":"2006","unstructured":"Decaudin D, de Cremoux P, Vincent-Salomon A, Dendale R, Lumbroso-Le Rouic L (2006) Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood 108:1451\u20131460","journal-title":"Blood"},{"key":"301_CR2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hon.741","volume":"22","author":"J Meunier","year":"2004","unstructured":"Meunier J, Lumbroso-Le Rouic L, Vincent-Salomon A, Dendale R, Asselain B, Arnaud P, Fourquet A, Desjardins L, Plancher C, Validire P, Chaoui D, Levy C, Decaudin D (2004) Ophthalmologic and intraocular non-Hodgkin\u2019s lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors. Hematol Oncol 22:143\u2013158","journal-title":"Hematol Oncol"},{"key":"301_CR3","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1200\/JCO.2005.07.083","volume":"23","author":"AJ Ferreri","year":"2005","unstructured":"Ferreri AJ, Ponzoni M, Guidoboni M, De Conciliis C, Resti AG, Mazzi B, Lettini AA, Demeter J, Dell\u2019Oro S, Doglioni C, Villa E, Bogliocchi M, Dolcetti R (2005) Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. J Clin Oncol 23:5067\u20135073","journal-title":"J Clin Oncol"},{"key":"301_CR4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/annonc\/mdj143","volume":"17","author":"B Grunberger","year":"2006","unstructured":"Grunberger B, Hauff W, Lukas J, Wohrer S, Zielinski CC, Streubel B, Chott A, Raderer M (2006) \u2018Blind\u2019 antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa. Ann Oncol 17:484\u2013487","journal-title":"Ann Oncol"},{"key":"301_CR5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0360-3016(98)00535-5","volume":"44","author":"TW Bolek","year":"1999","unstructured":"Bolek TW, Moyses HM, Marcus RB Jr, Gorden L 3rd, Maiese RL, Almasri NM, Mendenhall NP (1999) Radiotherapy in the management of orbital lymphoma. Int J Radiat Oncol Biol Phys 44:31\u201336","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"301_CR6","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0360-3016(02)02966-8","volume":"54","author":"S Bhatia","year":"2002","unstructured":"Bhatia S, Paulino AC, Buatti JM, Mayr NA, Wen BC (2002) Curative radiotherapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys 54:818\u2013823","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"301_CR7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ajh.10332","volume":"73","author":"EY Cho","year":"2003","unstructured":"Cho EY, Han JJ, Ree HJ, Ko YH, Kang YK, Ahn HS, Ahn SD, Park CJ, Huh J (2003) Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone B-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients. Am J Hematol 73:87\u201396","journal-title":"Am J Hematol"},{"key":"301_CR8","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.ophtha.2006.01.057","volume":"113","author":"GJ Ben Simon","year":"2006","unstructured":"Ben Simon GJ, Cheung N, McKelvie P, Fox R, McNab AA (2006) Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit. Ophthalmology 113:1209\u20131213","journal-title":"Ophthalmology"},{"key":"301_CR9","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","volume":"102","author":"A Conconi","year":"2003","unstructured":"Conconi A, Martinelli G, Thieblemont C, Ferreri AJM, Devizzi L, Peccatori F, Ponzoni M, Pedrinis E, Dell\u2019Oro S, Pruneri G, Filipazzi V, Dietrich PY, Gianni AM, Coiffier B, Cavalli F, Zucca E (2003) Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 102:2741\u20132745","journal-title":"Blood"},{"key":"301_CR10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000074641","volume":"65","author":"M Raderer","year":"2003","unstructured":"Raderer M, Jager G, Brugger S, Puspok A, Fiebiger W, Drach J, Wotherspoon A, Chott A (2003) Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. Oncology 65:306\u2013310","journal-title":"Oncology"},{"key":"301_CR11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.leukres.2004.05.011","volume":"29","author":"PL Zinzani","year":"2005","unstructured":"Zinzani PL, Alinari L, Stefoni V, Loffredo A, Pichierri P, Polito E (2005) Rituximab in primary conjunctival lymphoma. Leuk Res 29:107\u2013108","journal-title":"Leuk Res"},{"key":"301_CR12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00277-006-0134-0","volume":"85","author":"L Benetatos","year":"2006","unstructured":"Benetatos L, Alymara V, Asproudis I, Bourantas KL (2006) Rituximab as first line treatment for MALT lymphoma of extraocular muscles. Ann Hematol 85:625\u2013626","journal-title":"Ann Hematol"},{"key":"301_CR13","first-page":"1578","volume":"90","author":"AJM Ferreri","year":"2005","unstructured":"Ferreri AJM, Ponzoni M, Martinelli G, Muti G, Guidoboni M, Dolcetti R, Doglioni C (2005) Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa. Haematologica 90:1578\u20131580","journal-title":"Haematologica"},{"key":"301_CR14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.IOP.0000115594.98470.AC","volume":"20","author":"TJ Sullivan","year":"2004","unstructured":"Sullivan TJ, Grimes D, Bunce I (2004) Monoclonal antibody treatment of orbital lymphoma. Ophthal Plast Reconstr Surg 20:103\u2013106","journal-title":"Ophthal Plast Reconstr Surg"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-007-0301-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-007-0301-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-007-0301-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:44:57Z","timestamp":1559036697000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-007-0301-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,5]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["301"],"URL":"https:\/\/doi.org\/10.1007\/s00277-007-0301-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,5]]}}}